Perry Premdas

Perry Premdas

Director/Board Member at
OPX Biotechnologies, Inc.
73 year
Process Industries
Consumer Non-Durables
Health Technology

Profile

Perry W.
Premdas
is currently a Director at OPX Biotechnologies, Inc. He previously served as an Independent Director at Balchem Corp.
from 2008 to 2023, and as a Director at Fresenius Kabi Pharmaceuticals Holding LLC from 2008 to 2011.
Mr. Premdas also held various Director positions at Ferro Corp., J.
M.
Huber Corp., and HNA Holdings, Inc. Additionally, he served as the Chief Financial Officer at Celanese AG from 1999 to 2004 and at Centeon LLC from 1997 to 1998.
Mr. Premdas received his undergraduate degree from Brown University and his MBA from Harvard Business School.

Perry Premdas active positions

CompaniesPositionStart
Director/Board Member 31/12/2011

Former positions of Perry Premdas

CompaniesPositionEnd
BALCHEM CORPORATION Director/Board Member 21/06/2023
COMPASS MINERALS INTERNATIONAL, INC. Director/Board Member 30/04/2015
Director/Board Member 16/02/2011
Director of Finance/CFO 31/12/2003
Centeon LLC
Director of Finance/CFO 31/12/1997
See the detail of Perry Premdas's experience

Training of Perry Premdas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Consumer Non-Durables

Process Industries

Process Industries

Consumer Non-Durables

Process Industries

Process Industries

Health Technology

Health Technology

Consumer Services

Centeon LLC

Consumer Services